Articles > Popular publications > Business Wire press releases > January-March 2008 > Monday, March 31

Article: CSL Biotherapies Announces Afluria(R) Pre-Booking Open for 2008-2009 Flu Season.

Article from:
Business Wire
Article date:
March 31, 2008
Copyright

Newest entrant into U.S. market plans to deliver 6 million doses, largely thimerosal-free, pre-filled syringes

KING OF PRUSSIA, Pa. -- CSL Biotherapies announced today that healthcare providers now have the opportunity to pre-book Afluria[R] (influenza virus vaccine) through either www.afluria.com or at the company's toll-free number 1-888-435-8633. CSL Biotherapies, which entered the U.S. market last season, plans to produce approximately 6 million doses of Afluria for delivery in time for the upcoming season. The majority of the Afluria supply for the upcoming season will be in single-dose, thimerosal-free, pre-filled syringes.

"CSL has a 40-year track ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: CSL Biotherapies Announces First Shipments of ...
Vaccine Weekly;  September 24, 2008 ;     700+ words ... ... formed the basis for CSL Biotherapies' biologics licensing ... Safety Information Afluria should not be administered ... prescribing information on Afluria can be found at http://www.Afluria.com. About CSL Biotherapies The U.S. headquarters ...

Article: CSL Biotherapies Announces First Shipments of ...
Business Wire;  September 4, 2008 ;     700+ words ... ... six million Afluria doses KING ... Pa. -- CSL Biotherapies, a subsidiary ... basis for CSL Biotherapies' biologics ... Information Afluria should not ... www.Afluria.com. About CSL Biotherapies The U.S ...

Article: CSL Biotherapies Reaches Agreement with Merck & Co. ...
Vaccine Weekly;  October 14, 2009 ;     700+ words ... ... September 3, 2009. Afluria, a CSL product, is ... dose vials (see also CSL Biotherapies). Merck will have ... sell and distribute Afluria in the United States ... Ltd. will retain the Afluria license. "We are ... Perreault, President of CSL Biotherapies U.S. "CSL is committed ...

Article: CSL Biotherapies announces FDA marketing approval ...
Business Wire;  September 28, 2007 ;     700+ words ... ... PRUSSIA, Pa. -- CSL Biotherapies, a subsidiary ... has approved Afluria([R])(influenza ... Vice President of CSL Biotherapies Worldwide Commercial ... to be offering Afluria in a thimerosal ... s approval of Afluria, we welcome the ... suppliers and applaud CSL ...

Article: Phase III U.S. Pivotal Study Results on CSL ...
Pediatrics Week;  September 20, 2008 ;     700+ words ... ... formulations of CSL Biotherapies' influenza virus vaccine Afluria(R) elicited ... basis of CSL Biotherapies' US biologics ... application for Afluria that was ... basis for CSL Biotherapies' biologics ... Information Afluria should not ...

Article: Phase III U.S. Pivotal Study Results On CSL ...
Medical Letter on the CDC & FDA;  September 21, 2008 ;     700+ words ... ... formulations of CSL Biotherapies' influenza virus vaccine Afluria[R] elicited ... basis of CSL Biotherapies' US biologics ... application for Afluria that was ... basis for CSL Biotherapies' biologics ... Information Afluria should not ...

Article: Phase III U.S. Pivotal Study Results on CSL ...
Business Wire;  September 3, 2008 ;     700+ words ... ... formulations of CSL Biotherapies' influenza virus vaccine Afluria([R ... basis of CSL Biotherapies' US biologics ... application for Afluria that was ... basis for CSL Biotherapies' biologics ... Information Afluria should not ...

Article: Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for ...
Business Wire;  September 28, 2009 ;     700+ words ... ... exclusive agreement with CSL Biotherapies, a subsidiary of CSL ... market and distribute AFLURIA([R]) (Influenza ... after vaccination with AFLURIA. "Adult vaccines ... Infectious Diseases. "AFLURIA is an important addition ... adults in the U.S. CSL Biotherapies recently announced ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives